Inactive Instrument

Highlights Invion Ltd Australian S.E.

Stocks

IVX

AU000000CBZ4

Biotechnology & Medical Research

End-of-day quote Australian S.E. Other stock markets
- ^AUD	-

19/05	Invion signs first ophthalmology collaboration agreement with Sangmyung Innovation	RE
27/02	Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2025	CI

Highlights

27/02	Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2025	CI
27/25/27	Invion Limited Reports Earnings Results for the Full Year Ended June 30, 2025	CI
27/25/27	Invion Ltd post FY loss attributable A$8.8 million	RE
20/25/20	Invion Receives US FDA Orphan Drug Designation for Anal Cancer Drug Candidate; Shares Down 10%	MT
20/25/20	Invion says orphan drug designation granted by U.S. FDA for anal cancer	RE
05/25/05	Invion Terminates Share Purchase Agreement with Lind	MT
28/25/28	Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2024	CI
20/24/20	Reverse Split: 1 of 100	FA
30/24/30	Invion Limited Reports Earnings Results for the Full Year Ended June 30, 2024	CI
31/24/31	Invion Limited Announces Change of Company Secretary	CI
28/24/28	Invion Secures Institutional Funding from US-based Lind Partners; Shares Plunge 20%	MT
08/24/08	Invion Partners with Hanlim Pharma for Glioblastoma Treatment	MT
28/24/28	Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI
23/24/23	Invion Signs Collaboration Agreement with Dr. I&B Co for HPV Treatment; Shares Up 25%	MT
31/23/31	Invion Limited Reports Earnings Results for the Full Year Ended June 30, 2023	CI
06/23/06	Invion Limited agreed to acquire Next Generation Photodynamic Therapy of RMW Cho Group Limited.	CI
23/23/23	Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2022	CI
08/23/08	Invion Expanding Photosoft Technology Rights to US, Canada, Hong Kong	MT
26/22/26	Invion Limited Announces Vitro Test Results on Photosoft	CI
24/22/24	Invion Limited Announces the Positive Screening Results from in Vitro Studies of PhotosoftTM on the Inhibition of the Dengue Virus	CI
15/22/15	Invion Limited Announces INV043 Effective Against Anal Cancer Squamous Cell Carcinomas in Vitro	CI
08/22/08	Invion Limited Announces PhotosoftTM Shows Activity Against Zika Virus in Preliminary Assays	CI
18/22/18	Invion Limited Reports Earnings Results for the Full Year Ended June 30, 2022	CI
08/22/08	Invion Limited Announces International Patent to Extend IP Protection for Photosoft	CI
22/22/22	Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2021	CI